Delivery Order SPE2DR25D2005-SPE2DR26FE9G8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Zepbound 5 mg/0.5 mL pens valued at $1,072.79, with completion scheduled for December 22, 2025. This firm fixed-price, non-set-aside delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $46,091.55 for Zepbound 5 mg/0.5 ml pens on June 30, 2025, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction executed through AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,845.38 for Zepbound 2.5 mg/0.5 mL pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price contract, executed without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $88,527.23 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens scheduled for completion by December 19, 2025. This non-competitive delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 15 mg/0.5 mL pens with a ceiling value of $8,811.53. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors, with a contract ceiling value of $4,575.52. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,269.43 to supply Zepbound 10 mg/0.5 mL pens on a firm fixed price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by November 4, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will perform this work through its role as a critical pharmaceutical distributor supporting federal medical procurement needs. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $35,435.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 9, 2025, for Zepbound 7.5 mg/0.5 mL pens. The contract, which carries an ultimate completion date of September 10, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $10,039.95 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on December 18, 2025, with a completion date of December 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,746.02 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE9G8Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,819.99 for Zepbound 10 mg/0.5 ml pens on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, non-competitive delivery order fulfilled without a set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a competitively awarded contractor demonstrating capability to meet federal procurement requirements, AmerisourceBergen supports customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles, with this Zepbound delivery order representing a routine transaction within its broader pharmaceutical supply mission for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 12/18/25 |